NCT00827736

Brief Summary

The standard treatment of anal fissure in the netherlands (ISDN ointment) is being compared to a relatively new treatment (injection of Botox in the internal anal sphincter). The study hypothesis is that after 4 months, Botox has healed more patients than ISDN. The comparison is done blinded for the surgeon and the patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Jun 2002

Longer than P75 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2002

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2006

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2006

Completed
2.9 years until next milestone

First Submitted

Initial submission to the registry

January 20, 2009

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 23, 2009

Completed
Last Updated

January 23, 2009

Status Verified

January 1, 2009

Enrollment Period

3.8 years

First QC Date

January 20, 2009

Last Update Submit

January 22, 2009

Conditions

Keywords

anal fissurefissura anibotoxISDNNitric oxide donor

Outcome Measures

Primary Outcomes (1)

  • macroscopic healing of the fissure

    4 months

Secondary Outcomes (4)

  • complications

    12 months

  • fissure recurrence

    12 months

  • fissure related pain

    12 months

  • costs

    12 months

Study Arms (2)

Botox injection

EXPERIMENTAL

injection of 10U of BT (Botox®; Allergan, Irvine, California, USA) in the IAS on each side of the anterior midline. In addition, a placebo ointment has to be applied to the anoderm six times a day

Procedure: Botox

ISDN ointment

ACTIVE COMPARATOR

application of ISDN 1% ointment 6 times a day. injection of placebo into internal anal sphincter

Procedure: BotoxDrug: ISDN ointmentDrug: Placebo

Interventions

BotoxPROCEDURE

injection of 10U of BT (Botox®; Allergan, Irvine, California, USA) in the IAS on each side of the anterior midline.

Botox injectionISDN ointment

application of ISDN 1% ointment 6 times a day

ISDN ointment

Injection of placebo into internal anal sphincter (ISDN ointment arm) Applied to the anoderm six times a day (Botox injection arm)

ISDN ointment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • all consecutive patients over the age of 18 with a chronic anal fissure presenting to our surgical outpatient clinic

You may not qualify if:

  • pregnancy
  • previous anal surgery
  • Crohn's disease
  • systemic causes of an anal fissure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Onze Lieve Vrouwe Gasthuis

Amsterdam, North Holland, 1090 HM, Netherlands

Location

Related Publications (1)

  • Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med. 1999 Jul 8;341(2):65-9. doi: 10.1056/NEJM199907083410201.

MeSH Terms

Conditions

Fissure in Ano

Interventions

Botulinum Toxins, Type A

Condition Hierarchy (Ancestors)

Anus DiseasesRectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Intervention Hierarchy (Ancestors)

Botulinum ToxinsMetalloendopeptidasesEndopeptidasesPeptide HydrolasesHydrolasesEnzymesEnzymes and CoenzymesMetalloproteasesBacterial ProteinsProteinsAmino Acids, Peptides, and ProteinsBacterial ToxinsToxins, BiologicalBiological Factors

Study Officials

  • Michael Gerhards, MD

    Onze Lieve Vrouwe Gasthuis

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 20, 2009

First Posted

January 23, 2009

Study Start

June 1, 2002

Primary Completion

March 1, 2006

Study Completion

March 1, 2006

Last Updated

January 23, 2009

Record last verified: 2009-01

Locations